15.3 C
New York
Friday, September 29, 2023

This Is Too Hot For RAPT Therapeutics Inc. (NASDAQ: RAPT), Let’s Take A Closer Look

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for RAPT Therapeutics Inc. (RAPT) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $20.15. The RAPT Therapeutics Inc. has recorded 6,433 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Stocks Info

As a NASDAQ listed company, RAPT falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $20.15 and fluctuated between $20.20 as its day high and $19.30 as its day low. The current market capitalization of RAPT Therapeutics Inc. is $656.29M. A total of 0.18 million shares were traded on the day, compared to an average of 284.07K shares.

Insider Activity

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, RAPT has seen 2 BUY and 0 SELL insider trades, representing the acquisition of 1,380 and the disposition of 0 shares. Over the last 12 months, there were 12 BUYs and 9 SELLs from insiders. Insiders purchased 10,529 shares during that period but sold 37,742.

In the most recent transaction, HO WILLIAM sold 2,500 shares of RAPT for 18.92 per share on Aug 18. After the transaction, the Chief Medical Officer now owns 21,289 company shares. In a previous transaction on Apr 19, HO WILLIAM sold 5,000 shares at 18.88 per share. RAPT shares that Chief Medical Officer owns now total 20,992.

Among the insiders who bought shares, Robbins Wendye acquired of 2,500 shares on Mar 14 at a per-share price of $20.05. This resulted in the Director holding 6,500 shares of RAPT after the transaction. In another insider transaction, Robbins Wendye bought 2,500 shares at $18.99 per share on Mar 14. Company shares held by the Director now total 14,900.



In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for RAPT in the last 3 months, the mean price target is $38.60 with high estimates of $48.00 and low estimates of $21.00. In terms of 52-week highs and lows, RAPT has a high of $31.45 and a low of $15.59.

As of this writing, RAPT has an earnings estimate of -$0.75 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of -$0.68 per share and a lower estimate of -$0.82. The company reported an EPS of -$0.76 in the last quarter, which was -11.80% lower than expectations of -$0.68.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. RAPT’s latest balance sheet shows that the firm has $189.65M in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was $5.21, while its Total Shareholder’s Equity was $186.38M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RAPT is Buy with a score of 5.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles